Amgen
AMGN
#101
Rank
NZ$257.96 B
Marketcap
$479.91
Share price
-5.10%
Change (1 day)
6.72%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Amgen (AMGN) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$155.30 Billion

According to Amgen's latest financial reports the company's total assets are NZ$155.30 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Amgen - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$153.62 B49.78%
2022-12-31NZ$102.56 B14.54%
2021-12-31NZ$89.54 B2.64%
2020-12-31NZ$87.24 B-1.59%
2019-12-31NZ$88.65 B-10.46%
2018-12-31NZ$99.01 B-12.05%
2017-12-31NZ$112.57 B0.46%
2016-12-31NZ$112.06 B7.35%
2015-12-31NZ$104.39 B18.53%
2014-12-31NZ$88.07 B9.46%
2013-12-31NZ$80.46 B21.91%
2012-12-31NZ$66.00 B5.41%
2011-12-31NZ$62.61 B11.09%
2010-12-31NZ$56.36 B3.31%
2009-12-31NZ$54.56 B-13.12%
2008-12-31NZ$62.79 B38.87%
2007-12-31NZ$45.22 B-5.71%
2006-12-31NZ$47.96 B11.89%
2005-12-31NZ$42.86 B4.67%
2004-12-31NZ$40.95 B1.94%
2003-12-31NZ$40.17 B-14.04%
2002-12-31NZ$46.72 B201.17%
2001-12-31NZ$15.51 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$375.06 B 141.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$160.07 B 3.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$132.76 B-14.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$91.56 B-41.05%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$48.38 B-68.85%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$245.09 B 57.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$304.67 B 96.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.27 B-93.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$129.20 B-16.81%๐Ÿ‡บ๐Ÿ‡ธ USA